AI-generated analysis. Always verify with the original filing.
Sensus Healthcare, Inc. announced its financial results for the quarter and year ended December 31, 2025, reporting revenues of $4.9 million for the quarter and $27.5 million for the year, with a net loss of $3.2 million for the quarter and $7.7 million for the year. The company highlighted the publication of dedicated CPT codes for its SRT technology, providing reimbursement certainty, and expects sequential-quarter revenue growth in Q1 2026 and full-year profitability.
Event Type
Disclosure
Mandatory
Variant
8-K
, including in Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated
Financial Statements and Exhibits (d) Exhibits 99.1 Press Release, dated February 12, 2026. SIGNATURES Pursuant to the requirements of the Securities Exchange A
| Metric | Value | Basis |
|---|---|---|
| Revenue | $4.90 | GAAP |
| Gross Profit | $1.90 | GAAP |
| Gross Margin | 38.8% | GAAP |
| Net Loss | $3.20 | GAAP |
| Diluted EPS | $-0.19 | GAAP |
| Adjusted EBITDA | $-3.00 | Non-GAAP |
Shipments
exceed fourth quarter 2025 levels